Latest news
Price to earnings forward of Gubra A/S – FWB:PI3 - TradingViewTradingView · Wed, 05 Aug 2026 23:29:55 GMTAbbVie Weight Loss Drug: What the ABBV-295 Amylin Analog Delivers in Early Data *9FTA1nQ5q* - Diario ASDiario AS · Mon, 03 Aug 2026 11:47:20 GMTGubra sends asset to clinical trial and starts new front in the weight-loss race - medwatch.commedwatch.com · Tue, 28 Jul 2026 09:30:27 GMT